Starpharma Holdings Limited (SPHRF)

USD 0.07

(0.0%)

Revenue Summary of Starpharma Holdings Limited

  • Starpharma Holdings Limited's latest annual revenue in 2024 was 8.28 Million AUD , up 231.95% from previous year.
  • Starpharma Holdings Limited's latest quarterly revenue in 2024 FY was 8.28 Million AUD , up 182.03% from previous quarter.
  • Starpharma Holdings Limited reported a annual revenue of 2.93 Million AUD in annual revenue 2023, down -37.23% from previous year.
  • Starpharma Holdings Limited reported a annual revenue of 4.68 Million AUD in annual revenue 2022, up 160.4% from previous year.
  • Starpharma Holdings Limited reported a quarterly revenue of 4.01 Million AUD for 2024 Q1, up 116.54% from previous quarter.
  • Starpharma Holdings Limited reported a quarterly revenue of 7.19 Million AUD for 2024 Q2, up 79.36% from previous quarter.

Annual Revenue Chart of Starpharma Holdings Limited (2024 - 1998)

Historical Annual Revenue of Starpharma Holdings Limited (2024 - 1998)

Year Revenue Revenue Growth
2024 8.28 Million AUD 231.95%
2023 2.93 Million AUD -37.23%
2022 4.68 Million AUD 160.4%
2021 1.79 Million AUD -70.2%
2020 6.03 Million AUD 265.41%
2019 1.65 Million AUD -56.69%
2018 3.81 Million AUD 27.41%
2017 2.99 Million AUD -21.78%
2016 3.82 Million AUD 375.75%
2015 804 Thousand AUD 194.51%
2014 273 Thousand AUD 1265.0%
2013 20 Thousand AUD -97.84%
2012 925 Thousand AUD -19.14%
2011 1.14 Million AUD -18.52%
2010 1.4 Million AUD -30.46%
2009 2.01 Million AUD 42.99%
2008 1.41 Million AUD 63.45%
2007 863.85 Thousand AUD 172670.8%
2006 500.00 AUD -99.98%
2005 2.04 Million AUD 47.37%
2004 1.39 Million AUD -6.35%
2003 1.48 Million AUD 285.99%
2002 384.7 Thousand AUD 0.0%
2001 - AUD 0.0%
2000 - AUD 0.0%
1999 - AUD 0.0%
1998 - AUD 0.0%

Peer Revenue Comparison of Starpharma Holdings Limited

Name Revenue Revenue Difference
Evofem Biosciences, Inc. 18.21 Million USD 54.501%
Arch Therapeutics, Inc. 75.72 Thousand USD -10846.331%
CSL Limited 14.69 Billion USD 99.944%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 93.258%
Regen BioPharma, Inc. 236.56 Thousand USD -3403.974%
BioStem Technologies, Inc. 16.68 Million USD 50.322%
Capstone Therapeutics Corp. 48.35 Million USD 82.858%
Qrons Inc. - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD -329.037%
Oncotelic Therapeutics, Inc. 70 Thousand USD -11741.429%
Skye Bioscience, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD -1158.77%
Burzynski Research Institute, Inc. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.013%
Neon Bloom, Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 47.448%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -46940.463%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 61.407%
Intellipharmaceutics International Inc. 65.72 Thousand USD -12511.064%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD -40.444%
Marizyme, Inc. 645.81 Thousand USD -1183.504%
Genus plc 668.8 Million USD 98.761%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 96.621%
Therapeutic Solutions International, Inc. 98.99 Thousand USD -8273.235%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD -1920.894%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -10698.452%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -20875.252%
MultiCell Technologies, Inc. 49.32 USD -16806469.343%
ONE Bio Corp. 52.29 Million USD 84.15%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 83.329%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -16850.92%
Q BioMed Inc. 284.35 Thousand USD -2815.049%
Emmaus Life Sciences, Inc. 29.59 Million USD 71.994%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 94.287%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD -1386.256%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -829629.73%
Enzolytics Inc. 52.79 Thousand USD -15600.053%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD -1262.146%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.324%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD -5810.498%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD -1242.6%
Zenith Capital Corp. - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD -730.789%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD -3403.974%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD -505.478%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD -1649.731%
SYBLEU INC 11.69 Thousand USD -70770.383%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD -6.419%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -63661.538%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -20866.763%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD -148.919%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD -24.366%
IntelGenx Technologies Corp. 1.03 Million USD -697.786%
Gelesis Holdings, Inc. 25.76 Million USD 67.831%
CSL Limited 14.8 Billion USD 99.944%
Cellectis S.A. 755 Thousand USD -997.881%